Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Warren Buffett
Pharma
Berkshire Hathaway has exited stakes in AbbVie and BMS
The move comes after Berkshire Hathaway in 2020’s third quarter made a major splash in the healthcare arena.
Fraiser Kansteiner
May 17, 2022 9:25am
Buffett's Berkshire exits Merck before COVID pill boost
Nov 16, 2021 10:50am
Buffett's Berkshire cashed out on Biogen amid Aduhelm nod
Aug 17, 2021 11:32am
Buffett bets big on AbbVie, Bristol Myers, Merck, Pfizer
Nov 17, 2020 7:57am
Buffett's Berkshire bets $192M on Biogen ahead of AD drug filing
Feb 19, 2020 11:51am
Believer Buffett's big Teva investment sends shares soaring
Aug 16, 2018 10:57am
